Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North ...

In this technical session, Creative Biolabs has invited Dr. Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover, Dr.

The post-award management of NCBiotech grants and loans is administered NCBiotech's Contracts and Grants Department. If you have questions related to budget changes, project extensions, reporting or ...

Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, ...

Fresenius Kabi will expand its drug-manufacturing operations in Wilson, potentially bringing at least 445 new jobs over five years and $100 million in investment. The German company will enlarge its ...

Dova Pharmaceuticals of Durham has received approval from the U.S. Food and Drug Administration for its first commercial drug, a tablet for treating thrombocytopenia, or low blood platelet counts, ...

Fervent Pharmaceuticals of Greenville has successfully submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for FP-101, its proprietary lead drug candidate ...

The addition of North Carolina to the Mid-Atlantic Bio geography solidifies the conference’s position as the leading regional life-sciences event. Expected to attract more than 1,000 attendees from ...

The North Carolina One Health Collaborative seeks to promote and improve the health and well-being of all species by enhancing collaboration among physicians, veterinarians, researchers, and other ...

Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases ...

When pharmaceutical companies win regulatory approval for a drug to be sold – a long and expensive journey that requires successful phase 1, 2 and 3 clinical trials – their work is far from over. They ...

The Conference Center at NCBiotech will be closed on Nov. 27, 2024. Also, NCBiotech's offices will be closed on Nov. 28-29, 2024, for the Thanksgiving holiday.